252 related articles for article (PubMed ID: 27301890)
1. Retraction: "Over-expression of FoxM1 leads to epithelial-mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cells" by Bao et al.
J Cell Biochem; 2016 Aug; 117(8):1963. PubMed ID: 27301890
[TBL] [Abstract][Full Text] [Related]
2. Retraction: "Down-regulation of Notch-1 is associated with Akt and FoxM1 in inducing cell growth inhibition and apoptosis in prostate cancer cells" by Wang et al.
J Cell Biochem; 2016 Aug; 117(8):1962. PubMed ID: 27301889
[TBL] [Abstract][Full Text] [Related]
3. Retraction: "Down-regulation of uPA and uPAR by 3,3'-diindolylmethane contributes to the inhibition of cell growth and migration of breast cancer cells" by Ahmad et al.
J Cell Biochem; 2016 Aug; 117(8):1959. PubMed ID: 27301886
[TBL] [Abstract][Full Text] [Related]
4. Retraction: "Activated K-Ras and INK4a/Arf Deficiency Promote Aggressiveness of Pancreatic Cancer by Induction of EMT Consistent With Cancer Stem Cell Phenotype" by Wang et al.
J Cell Physiol; 2016 Oct; 231(10):2304. PubMed ID: 27315162
[TBL] [Abstract][Full Text] [Related]
5. Retraction: "Concurrent inhibition of NF-κB, cyclooxygenase-2, and epidermal growth factor receptor leads to greater anti-tumor activity in pancreatic cancer" by Ali et al.
J Cell Biochem; 2016 Aug; 117(8):1961. PubMed ID: 27301888
[TBL] [Abstract][Full Text] [Related]
6. Retraction: "Inactivation of Ink4a/Arf Leads to Deregulated Expression of miRNAs in K-Ras Transgenic Mouse Model of Pancreatic Cancer" by Ali et al.
J Cell Physiol; 2016 Oct; 231(10):2303. PubMed ID: 27315161
[TBL] [Abstract][Full Text] [Related]
7. Retraction: "Down-regulation of Notch-1 and Jagged-1 inhibits prostate cancer cell growth, migration and invasion, and induces apoptosis via inactivation of Akt, mTOR, and NF-κB signaling pathways" by Wang et al.
J Cell Biochem; 2016 Aug; 117(8):1960. PubMed ID: 27301887
[TBL] [Abstract][Full Text] [Related]
8. Retraction.
Int J Cancer; 2016 Nov; 139(9):2146. PubMed ID: 27534920
[TBL] [Abstract][Full Text] [Related]
9. Retraction.
Cancer; 2016 Oct; 122(20):3247. PubMed ID: 27696401
[TBL] [Abstract][Full Text] [Related]
10. Retraction.
Cancer; 2016 Oct; 122(20):3247. PubMed ID: 27696400
[TBL] [Abstract][Full Text] [Related]
11. Retraction.
Int J Cancer; 2016 Nov; 139(9):2146. PubMed ID: 27534921
[TBL] [Abstract][Full Text] [Related]
12. Retraction.
Int J Cancer; 2016 Nov; 139(9):2145. PubMed ID: 27534918
[TBL] [Abstract][Full Text] [Related]
13. Retraction.
Int J Cancer; 2016 Nov; 139(9):2145. PubMed ID: 27534919
[TBL] [Abstract][Full Text] [Related]
14. Retraction.
Int J Cancer; 2016 Nov; 139(9):2145-6. PubMed ID: 27534917
[TBL] [Abstract][Full Text] [Related]
15. Retraction.
Cancer; 2016 Oct; 122(20):3248. PubMed ID: 27696403
[TBL] [Abstract][Full Text] [Related]
16. Retraction.
J Cell Biochem; 2021 Dec; 122(12):1971. PubMed ID: 34555205
[TBL] [Abstract][Full Text] [Related]
17. Retraction.
Cancer; 2016 Oct; 122(20):3248. PubMed ID: 27696404
[TBL] [Abstract][Full Text] [Related]
18. Retraction: "Identification of Novel Biomarkers for Pancreatic Cancer Using Integrated Transcriptomics With Functional Pathways Analysis" by Zhang, X., Tong, P., Chen, J., Pei, Z., Zhang, X., Chen, W., Xu, J. and Wang, J.
J Cell Physiol; 2017 Nov; 232(11):3197. PubMed ID: 26909671
[TBL] [Abstract][Full Text] [Related]
19. Retraction.
Int J Cancer; 2015 Oct; 137(8):2041. PubMed ID: 26252813
[TBL] [Abstract][Full Text] [Related]
20. Retraction.
J Cell Biochem; 2021 May; 122(5):600. PubMed ID: 33786921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
